News Valneva Xetra

Equities

AYJ

FR0004056851

Market Closed - Xetra Other stock markets 09:05:53 17/05/2024 pm IST			5-day change	1st Jan Change
4.01 ^EUR	+0.20%		+21.15%	-15.56%

13/05	Valneva: new positive data in CHIKV	CF
07/05	Valneva SE Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Valneva: new positive data in CHIKV	13/05	CF
Valneva Reports Further Positive Pivotal Phase 3 Data in Adolescents for its Single-Shot Chikungunya Vaccine	13/05	GL
Valneva Reports Further Positive Pivotal Phase 3 Data in Adolescents for its Single-Shot Chikungunya Vaccine	13/05	AQ
Valneva SE Reports Earnings Results for the First Quarter Ended March 31, 2024	07/05	CI
Transcript : Valneva SE, Q1 2024 Earnings Call, May 07, 2024	07/05
Valneva: quarterly results boosted by PRV sale	07/05	CF
Valneva : Q1 2024 Financial Results	07/05	PU
Valneva : Reports First Quarter 2024 Financial Results and Provides Corporate Updates	07/05	PU
Valneva Reports First Quarter 2024 Financial Results and Provides Corporate Updates	07/05	GL
Valneva SE Confirms Earnings Guidance for the Fiscal Year 2024	07/05	CI
Valneva : Document AMF CP. 2024E960493	16/04	PU
Valneva: Deep Track Biotechnology Master holds less than 5% of the capital	11/04	CF
World Vaccine Congress Washington: Antibody persistence of a single-dose live-attenuated chikungunya virus vaccine in adults	04/04	PU
Valneva Kicks Off Early-stage Trial for Zika Vaccine Candidate	26/03	MT
Valneva: Phase 1 trial initiated in the Zika virus	26/03	CF
Valneva Initiates Phase 1 Trial of Second-Generation Zika Vaccine Candidate	26/03	AQ
Valneva Initiates Phase 1 Trial of Second-Generation Zika Vaccine Candidate	26/03	GL
Valneva SE Initiates Phase 1 Trial of Second-Generation Zika Vaccine Candidate	26/03	CI
Valneva Announces Filing of 2023 Universal Registration Document and US Form 20-F	25/03	GL
Valneva Announces Filing of 2023 Universal Registration Document and US Form 20-F	25/03	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Valneva Xetra

Equities

AYJ

FR0004056851

Summary

Filters